» Articles » PMID: 14551752

Clinical Value of FDG PET in Patients with Fever of Unknown Origin and Patients Suspected of Focal Infection or Inflammation

Overview
Date 2003 Oct 11
PMID 14551752
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Fever of unknown origin (FUO) and suspected focal infection or inflammation are challenging medical problems. The aim of this study was to assess the value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients with FUO and patients with suspected focal infection or inflammation. All FDG PET scans ordered because of FUO or suspected focal infection or inflammation in the last 4 years were reviewed. These results were compared with the final diagnosis. Thirty-five FDG PET scans were performed in 35 patients with FUO. A final diagnosis was established in 19 patients (54%). Of the total number of scans, 37% were clinically helpful. The positive predictive value of FDG PET in these patients was 87% and the negative predictive value was 95%. Fifty-five FDG PET scans were performed in 48 patients with suspected focal infection or inflammation. A final diagnosis was established in 38 patients (82%). Of the total number of scans, 65% were clinically helpful. The positive predictive value of FDG PET in these 55 episodes of suspected infection or inflammation was 95% and the negative predictive value was 100%. It is concluded that FDG PET appears to be a valuable imaging technique in the evaluation of FUO and suspected focal infection or inflammation. Furthermore, FDG PET could become a useful tool for evaluating the effect of treatment of infectious and inflammatory processes that cannot reliably be visualised by conventional techniques. However, to assess the additional diagnostic value of this technique, prospective studies of FDG PET as part of a structured diagnostic protocol are warranted.

Citing Articles

Diagnostic efficacy and necessity of 18F-FDG PET/CT in fever of unknown origin: insights from a retrospective cohort study.

Yu X, Wang S, Du N, Zhao H, Chen H Front Med (Lausanne). 2025; 11:1511710.

PMID: 39995828 PMC: 11847851. DOI: 10.3389/fmed.2024.1511710.


Clinical and metagenomic characteristics of lymphadenopathy related to fever of unknown origin in children.

Zhou Y, Shen N, Luo L, Liu Y, Cao Q Pediatr Res. 2024; 96(4):1037-1044.

PMID: 38678116 PMC: 11502501. DOI: 10.1038/s41390-024-03187-3.


Value of Positron Emission Tomography Coupled With Computed Tomography for the Diagnosis of Inflammatory Syndrome of Unknown Origin in an Internal Medicine Department.

Boulu X, El Esper I, Meyer M, Duhaut P, Salle V, Schmidt J Mayo Clin Proc Innov Qual Outcomes. 2023; 7(3):178-186.

PMID: 37206378 PMC: 10189090. DOI: 10.1016/j.mayocpiqo.2023.04.001.


Simultaneous Detection of Pathogens and Tumors in Patients With Suspected Infections by Next-Generation Sequencing.

Su J, Han X, Xu X, Ding W, Li M, Wang W Front Cell Infect Microbiol. 2022; 12:892087.

PMID: 35755839 PMC: 9218804. DOI: 10.3389/fcimb.2022.892087.


F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.

Beck M, Hartwich J, Eckstein M, Schmidt D, Gostian A, Muller S Ann Nucl Med. 2022; 36(7):623-633.

PMID: 35534690 PMC: 9226092. DOI: 10.1007/s12149-022-01744-6.


References
1.
Blockmans D, Stroobants S, Maes A, Mortelmans L . Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000; 108(3):246-9. DOI: 10.1016/s0002-9343(99)00424-6. View

2.
De Winter F, Vogelaers D, Gemmel F, Dierckx R . Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis. 2002; 21(4):247-57. DOI: 10.1007/s10096-002-0708-2. View

3.
Guhlmann A, Suger G, Glatting G, Kotzerke J, Kinzl L, Reske S . Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med. 1998; 39(12):2145-52. View

4.
Lorenzen J, Buchert R, Bohuslavizki K . Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001; 22(7):779-83. DOI: 10.1097/00006231-200107000-00009. View

5.
Petersdorf R, Beeson P . Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961; 40:1-30. DOI: 10.1097/00005792-196102000-00001. View